NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
UNITED STATES |
OMB APPROVAL |
OMB Number: |
3235-0080 |
Expires: |
March 31, 2018 |
Estimated average burden |
hours per response: |
1.7 |
|
|
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
FORM 25 |
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
Commission File Number |
000-22286 |
|
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
|
Address: |
Five Skyline Drive |
|
Hawthorne |
NEW YORK |
10532 |
Telephone number: |
| 914-345-9001 |
|
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
|
Ordinary Shares |
(Description of class of securities)
|
|
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
|
|
Pursuant to the requirements fo the Securities Exchange Act of 1934,
NASDAQ Stock Market LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
|
2007-01-18 |
By |
Amy Horton |
|
Associate General Counsel |
Date |
|
Name |
Title |
|
1 |
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
|
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
|
Delisting Determination,The Nasdaq Stock Market, LLC, January
29, 2007, Taro Phamaceutical Industries Ltd. The Nasdaq Stock
Market, LLC (the Exchange) has determined to remove from
listing the ordinary shares of Taro Pharmaceuticals Industries Ltd.
(the Company), effective at the opening of business on
February 8, 2007.Based on a review of the information
provided by the Company, Nasdaq Staff determined that
the Company no longer qualified for listing on the Exchange
as it failed to comply with the following Marketplace Rules:
4310(c)(14). The Company was notified of Staffs determination
on July 19, 2006. The Company requested a review of the Staffs
determination before the Listing Qualifications Hearings
Panel. Upon review of the information provided by the Company,
the Panel determined that the Company did not qualify for
inclusion on the Exchange based on its failure to comply with
the following Marketplace Rules: 4310(c)(14). The Company was
notified of the Panels decision on December 12, 2006 and trading
in the Companys securities was suspended on December 14, 2006.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The Listing
Council did not call the matter for review. The
Panels Determination to delist the Company became final on
January 26, 2007.